Association of immune marker changes with progression of monoclonal gammopathy of undetermined significance to multiple myeloma
JAMA Oncology Jul 24, 2019
Landgren O, et al. - In this prospective cross-sectional cohort investigation, researchers longitudinally examined the changes of serum immune markers with stable vs progressive monoclonal gammopathy of undetermined significance (MGUS), given that multiple myeloma is consistently preceded by MGUS. They found that IgA isotype, 15 g/L or more monoclonal spike, skewed (<0.1 or >10) serum free light chains ratio, and severe immunoparesis (≥2 suppressed uninvolved immunoglobulins) were risk factors related to progressive MGUS in cross-sectional modeling. Skewed serum free light chains ratio and severe immunoparesis were identified as risk factors related to progressive light-chain MGUS. In longitudinal inquiry of participants with serial samples before progression, a high-risk MGUS before progression was detected in 23 of 43 participants (53%). Within 5 years, conversion from low-risk or intermediate-risk MGUS was reported in 16 of these 23 (70%) participants. For light-chain MGUS, similar findings were obtained.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries